The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 07, 2018
Filed:
Aug. 29, 2014
Applicant:
Daewoong Pharmaceutical Co., Ltd., Gyeonggi-do, KR;
Inventors:
Kyung A Yu, Gyeonggi-do, KR;
Ji Sung Yoon, Gyeonggi-do, KR;
Deok Ki Eom, Gyeonggi-do, KR;
Yeon Im Lee, Gyeonggi-do, KR;
Mi Ryeong Han, Gyeonggi-do, KR;
Jun Hee Lee, Seoul, KR;
Ha Nee Seo, Gyeonggi-do, KR;
Ji Duck Kim, Gyeonggi-do, KR;
Sang Ho Lee, Gyeonggi-do, KR;
Assignee:
Daewoong Pharmaceutical Co., Ltd., Gyeonggi-do, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4035 (2006.01); A61K 31/4439 (2006.01); C07D 209/44 (2006.01); C07D 209/52 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 403/12 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 405/10 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 409/04 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4035 (2013.01); A61K 31/4439 (2013.01); C07D 209/44 (2013.01); C07D 209/52 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 409/04 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention provides tetrahydrocyclopentapyrrole derivatives that can be used for preventing or treating peptic ulcer, gastritis or reflux esophagitis, a method for preparing the same, and a pharmaceutical composition containing the same.